Skip to main contentSkip to navigation
Sirius Investors
Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc.

RXRX
NASDAQHealthcare

Revenue Analysis - RXRX

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

RXRX Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

License and Service

0.0% of total revenue

$6.3M

Grant

0.0% of total revenue

$171.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Grant
License and Service
3/31/2026$171.0K$6.3M
12/31/2025$186.0K$35.4M
9/30/2025$192.0K$5.0M
6/30/2025$120.0K$19.1M
3/31/2025$-73000$14.8M
12/31/2024$48.0K$18.9M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
License and Service-82.2%

Geographic Regions

Growing Regions
UNITED STATES+1427.8%

Earnings Reports

Want to see how RXRX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports